<p>A method of evaluating the degree of cancerization of a specimen originating in a mammal characterized by comprising: (1) the first step of measuring the methylation frequency or an indication correlating thereto in Fibrillin 2 gene contained in the mammal-origin specimen; and (2) the second step of judging the degree of cancerization of the above-described specimen based on the difference obtained by comparing the methylation frequency or the indication correlating thereto having been measured above with the data of a control; and so on.</p>
申请公布号
WO2005026350(A1)
申请公布日期
2005.03.24
申请号
WO2004JP13871
申请日期
2004.09.15
申请人
SUMITOMO CHEMICAL COMPANY, LIMITED;JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CANCER CENTER;USHIJIMA, TOSHIKAZU;HAGIHARA, ATSUSHI